Publication Date:
2015-12-10
Description:
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia Leukemia 29, 2338 (December 2015). doi:10.1038/leu.2015.164 Authors: I M Ghobrial, R Redd, P Armand, R Banwait, E Boswell, S Chuma, D Huynh, A Sacco, A M Roccaro, A Perilla-Glen, K Noonan, M MacNabb, H Leblebjian, D Warren, P Henrick, J J Castillo, P G Richardson, J Matous, E Weller & S P Treon
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink